A Phase 1b/2 Study to Evaluate LB-100 for Advanced Soft Tissue Sarcoma
Latest Information Update: 03 Mar 2021
At a glance
- Drugs LB 100 (Primary)
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Lixte Biotechnology Holdings
- 03 Mar 2021 New trial record